# Bateman et al. 2021 - Mayo Clinic Proceedings ME/CFS Consensus

## Citation
Bateman L, Bested AC, Bonilla HF, Chheda BV, Chu L, Curtin JM, Dempsey TT, Dimmock ME, Dowell TG, Felsenstein D, Kaufman DL, Klimas NG, Komaroff AL, Lapp CW, Levine SM, Montoya JG, Natelson BH, Peterson DL, Podell RN, Rey IR, Ruhoy IS, Vera-Nunez MA, Yellman BP. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management. *Mayo Clinic Proceedings*. 2021 Nov;96(11):2861-2878.

- **DOI:** 10.1016/j.mayocp.2021.07.004
- **PMID:** 34454716
- **BibTeX key:** `Bateman2021mayo`

## Key Points

### Diagnostic Guidelines
- **Adopt 2015 National Academy of Medicine diagnostic criteria**
- **Up to 91% of U.S. patients remain undiagnosed** (critical diagnostic gap)
- PEM as cardinal diagnostic feature

### Treatment Recommendations
- **Withdraw graded exercise therapy (GET)** - governments and health organizations now discourage for ME/CFS
- Pacing as primary management approach
- Symptom-targeted treatments

### Authors
21 leading ME/CFS clinician-researchers including:
- Lucinda Bateman (Bateman Horne Center)
- David Kaufman (Center for Complex Diseases)
- Nancy Klimas (INIM)
- Anthony Komaroff (Harvard)
- Jose Montoya (Stanford)
- Benjamin Natelson (Icahn School of Medicine)
- Daniel Peterson (Sierra Internal Medicine)

## Significance
- **Gold-standard consensus guidelines** from U.S. ME/CFS Clinical Coalition
- Published in Mayo Clinic Proceedings (high credibility)
- **In top 1% most shared** of all Mayo Clinic publications

## Certainty Assessment
- **Quality:** High (21 expert consensus, premier clinical journal)
- **Type:** Synthesis of existing evidence (not single study)
- **Status:** Authoritative source for diagnostic and management recommendations

## Integration Points
- Chapter on Diagnostic Criteria
- Chapter on Prevalence and Epidemiology
- Chapter on Treatment Contraindications (GET)
- Chapter on Clinical Management